GlassScriptPhysician profile
Rolando H Saenz
NPI 1316962723
$15,420.73
in general payments reported to CMS, 2019-2025
16 companies · $1,663 in 2025
The $1,663 reported for 2025 was more than what 80% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,879 · 2020: $102 · 2022: $1,479 · 2023: $3,230 · 2024: $68.28 · 2025: $1,663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,207 · Travel and Lodging: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,206.70 |
| Travel and Lodging | $754.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,197.20 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Kci USA, INC. | $263.40 | 2019-2020 | |
| Davol INC. | $185.91 | 2022 | |
| Sanara Medtech INC. | $156.62 | 2025 | Celleraterx |
| Tela Bio, INC. | $149.29 | 2019-2020 | |
| Conmed Corporation | $116.06 | 2023 | Airseal, Abc Handpieces, Visiclear |
| Tei Biosciences INC | $94.08 | 2019 | |
| Integra Lifesciences Corporation | $87.64 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Shire North American Group INC | $45.47 | 2019 | |
| Biotissue Holdings INC. | $31.94 | 2024 | |
| Kerecis Limited | $26.61 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.65 | 2025 | Gattex |
| Smith+Nephew, INC. | $14.95 | 2019 | |
| Acera Surgical, INC. | $12.07 | 2020 | |
| Bard Access Systems, INC. | $11.72 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolando Saenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.